Clinical Trials on Depressed Mood in Japan

Total 80 results

GlaxoSmithKline

Completed

Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects

Depressive Disorder

Japan
GlaxoSmithKline

Completed

Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects

Depressive Disorder

Japan
Shionogi
Eli Lilly and Company

Completed

A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder

Depressive Disorder

Japan
Shionogi
Eli Lilly and Company

Terminated

A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder

Depressive Disorder

Japan
Ashikaga Red Cross Hospital

Completed

Response of Psychiatric Outpatients to the Great East Japan Earthquake

Mood Disorders

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Food Effect Study of TS-142 in Healthy Subjects

Effect of Food

Japan
Kyoto University
Nagoya City University

Completed

Telephone Cognitive-Behavioral Therapy (CBT) for Subthreshold Depression and Presenteeism in Workplace

Depression

Japan
Mochida Pharmaceutical Company, Ltd.
Pfizer

Completed

A Study of MD-120 in Patients With Depression

Major Depressive Disorder

Japan
Kibi International University

Completed

Study Protocol for a Smartphone Application-based Intervention for Subthreshold Depression

Subthreshold Depression

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial of OPC-64005 for Major Depressive Disorder

Major Depressive Disorder

Japan
Gunma University

Completed

Treating Depressed Mood With a Smartphone-delivered Positive Word Stimulation for Subthreshold Depression

Subthreshold Depression

Japan
Kibi International University

Completed

Smartphone Intervention for Subthreshold Depression

Subthreshold Depression

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of Brexpiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Chiba University

Completed

An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression

Adolescent | Depression

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.

Active, not recruiting

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Bipolar Disorder I

Japan
Astellas Pharma Inc

Completed

Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Showa University

Completed

Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder (AFADTRMDD)

Major Depressive Disorder

Japan
Pfizer

Completed

Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect

Food | Therapeutic Equivalency

Japan
National Center of Neurology and Psychiatry, Japan

Completed

Japan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP Study)

Anxiety Disorders | Depressive Disorders

Japan
Astellas Pharma Inc

Completed

Oral Multiple-dose Study in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
National Center of Neurology and Psychiatry, Japan

Completed

Happy Nurse Project: Lifestyle Interventions to Maintain Healthy Mental State in Hospital Nurses (HNP)

Depressive Disorder | Anxiety Disorders

Japan
Nagoya City University

Completed

Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression

Major Depressive Disorder

Japan
Astellas Pharma Inc

Completed

Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder

Major Depressive Disorder Patients

Japan
Astellas Pharma Inc

Completed

Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder

Major Depressive Disorder Patients

Japan
Institute for Health Economics and Policy, Japan
Senzoku Stress Coping Support Office

Recruiting

Schema Therapy for Chronic Depression

Dysthymic Disorder | Chronic Depressive Disorder

Japan
Astellas Pharma Inc

Completed

Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder

Major Depressive Disorder

Japan
GlaxoSmithKline

Completed

Study Of 323U66 SR In Major Depressive Disorder

Depressive Disorder

Japan
National Center of Neurology and Psychiatry, Japan

Terminated

Transcranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary Research (ADAPT)

Depression | Alzheimer Disease

Japan
Kibi International University

Unknown

iPad Application-based Intervention for Post-stroke Depression

Post-stroke Depression

Japan
Nagoya City University
Kochi University

Completed

Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory Insomnia

Major Depressive Disorder

Japan
GlaxoSmithKline

Completed

Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan

Major Depressive Disorder (MDD)

Japan
University of Jazan
Saudi Board of Community Medicine

Completed

Effects of an Educational Program on Depression Literacy and Stigma Among Secondary School Students in Jazan City

Depression Literacy | Depression Stigma

Saudi Arabia
Eli Lilly and Company

Completed

A Study of LY2216684 in Participants With Major Depression Disorder

Major Depressive Disorder

Japan
GlaxoSmithKline

Terminated

Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)

Depressive Disorder

Japan
GlaxoSmithKline

Completed

Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors

Depressive Disorder

Japan
Eli Lilly and Company

Completed

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Eli Lilly and Company

Completed

A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing

Major Depressive Disorder

Japan
Pfizer

Completed

Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)

Major Depressive Disorder

Japan
Takeda

Completed

The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy

Insomnia | Major Depressive Disorder

Japan
Sumitomo Pharma Co., Ltd.

Completed

A Phase III Study of SM-13496 in Patients With Bipolar I Depression.

Bipolar Depression

Lithuania, Malaysia, Russian Federation, Slovakia, Ukraine, Japan, Philippines, Taiwan
Nazlin Walji

Recruiting

Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients (ELICE_BD)

Bipolar Disorder

United States, Canada, Japan, United Kingdom
GlaxoSmithKline

Completed

Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)

Depressive Disorder

Korea, Republic of, Japan
GlaxoSmithKline

Completed

A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)

Depressive Disorder, Major

Korea, Republic of, Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Effexor XR in Elderly Patients With Major Depression.

Depression

Japan
Solvay Pharmaceuticals

Completed

Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents

Major Depressive Disorder

Japan
Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Slovakia, Poland, Hungary, Japan, Russian Federation
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

Major Depressive Disorder

Japan

3

Subscribe